Intelligence · Clinical Development
Pipeline search results
Programs matching “pneumococcal” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 24 pipeline programs matching "pneumococcal" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
12-Valent Pneumococcal Conjugate Vaccine
MAIA Biotechnology
Pneumococcal Vaccines
1 trial -
PCV21
Sanofi Pasteur
Pneumococcal Infections
1 trial -
PCV21 vaccine
Sanofi Pasteur
Pneumococcal Immunization
1 trial -
PSK00010
Sanofi-aventis Healthcare Pty Ltd
Pneumococcal immunisation
1 trial -
PSK04
Sanofi-aventis Healthcare Pty Ltd
Pneumococcal Immunization
1 trial -
Prevnar 13™
Merck KGaA, Darmstadt, Germany
Pneumococcal Infections
1 trial -
Sinovac PCV13
Sinovac Research and Development Co.,
Pneumococcal Infectious Diseases
1 trial -
Sinovac PCV13
Sinovac Research and Development Co.,
Pneumococcal Infectious Disease
2 trials -
V114
Merck KGaA, Darmstadt, Germany
Pneumococcal Infections
1 trial -
V116-013
Merck Sharp and Dohme
Pneumococcal disease
1 trial -
Walvax PCV13-TT
Biotech Pharmaceutical Co.,
Pneumococcal Disease, Invasive
1 trial -
pneumococcal disease prevention
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Pneumococcal Vaccines
1 trial -
Sinovac Low-dosage PCV24
Sinovac Research and Development Co.,
Pneumococcal Infectious Disease
1 trial -
Sinovac PCV24
Sinovac Research and Development Co.,
Pneumococcal Infectious Disease
2 trials -
pneumococcal polysaccharide and protein conjugate vaccines
United Therapeutics Europe Ltd
Pneumococcal Infections
1 trial -
15-Valent Pneumococcal Conjugate Vaccine
BRIGHT MINDS BIOSCIENCES INC.
Pneumonia, Pneumococcal
1 trial -
Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
Sinovac Research and Development Co.,
Pneumococcal Infections
1 trial -
PCV-LITE-I
Teva Pharma GmbH
Pneumococcal infection
1 trial -
Pneumococcal Vaccine, Polyvalent (23-valent)
Praxis Precision Medicines
HIV Infections
1 trial -
Sinovac PCV24 formulation 1
Sinovac Research and Development Co.,
Pneumococcal Infectious Disease
2 trials -
23-valent pneumococcal polysaccharide vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Vaccination
1 trial -
Experimental 23-valent PPV
Sinovac Research and Development Co.,
Pneumococcal Infections
1 trial -
Experimental 23-valent Pneumococcal
Sinovac Research and Development Co.,
Pneumococcal Infections
1 trial -
Investigational 23-valent PPV
Sinovac Research and Development Co.,
Pneumococcal Infections
2 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.